Exponential Medicine conference day 2 summary
Medgadget - 13-Nov-2015Summary of all the day 2 speakers, including: Omics, Biotech, and Beyond Genomes to People (G2P...
Join the club for FREE to access the whole archive and other member benefits.
Chief medical information officer and assistant medical director for Kaiser Permanente.
John Mattison, is the Chief Medical Information Officer and Assistant Medical Director for Kaiser Permanente. He focuses on transforming care delivery with information technology, through convergence of exponential technologies and data liquidity. He led the design and implementation of the largest integrated electronic health record in the US, and leads various national programs including virtual care. He has sponsored or led numerous digital innovations, and mentors many digital health startups. He chairs the eHealth Workgroup of the Global Alliance for Genomics and Health (GA4GH), and is a board member of Open mHealth, advisory board member of the NIH funded Policy and Ethics in Precision Medicine, teaches at multiple Universities including Singularity University, and has published widely on privacy, policy, security, IOT, global genomics collaboration, interoperability, mobile health, and healthcare transformation. He has published in Nature, JAMIA, JAMA, WSJ, Forbes, and has authored chapters for various books. He has keynoted or hosted many national and international healthcare conferences and has consulted in many countries. He is the founder of the international XML standard for health record interoperability known as CDA, CCD and CCDA, and is an active participant on several global initiatives to bring internet services to underserved communities providing access to both jobs and healthcare. Full bio available upon request.
Visit website: https://www.crunchbase.com/person/john-mattison#section-overview
See also: Kaiser Permanente - America's leading health care providers and not-for-profit health plans.
Details last updated 25-Jun-2020
Summary of all the day 2 speakers, including: Omics, Biotech, and Beyond Genomes to People (G2P...